ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · ARX

Atlas market file · Equity · United States

Accelerant HoldingsARX

Last close
12.29
Change
+0.24%
96-bar range
10.765 – 17.85
As of
6 Aug 2026

Accelerant Holdings is an insurance agents, brokers & service issuer listed as ARX on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:ARX

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

18.062616.18514.307512.4310.552520 Mar29 May06 Aug

up candle   down candle

Latest close12.29
Day change+0.24%
Window high17.85
Window low10.765
96-bar change-5.10%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 56 weekly closes (-58.74% over the window).

30.84169.468421 Jul06 Aug

Source rail: Yahoo Finance chart API (ARX). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for ARX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

ARX public profile

Company

Insurance agents, brokers & service issuer. Accelerant Holdings is connected to current market context, cited company sources and its retained research file.

Market

Accelerant Holdings trades as ARX on NYSE. Accelerant Holdings (ARX) has a latest verified close of 12.29, up 0.24%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ARX under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Accelerant Holdings does not become simple just because ARX looks tidy. Accelerant Holdings is listed on NYSE in United States with TradingView symbol NYSE:ARX and public listing evidence. The market can compress a company into four letters, but the real story still has departments, customers, product choices, capital needs, margins, competitors, and the occasional executive sentence trying to sound heavier than it is. The honest opening stays with the operating record: what Accelerant Holdings actually sells, what the filings and cash line show, and which disclosed number would move ARX from a described claim to a proven one (source: public profile, https://atlas.freedomcore.io/stocks/ARX/).

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Accelerant Holdings today

Open full report
ARX daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Accelerant Holdings (Accelerant Risk Exchange) is a specialty-insurance platform that pitches itself as a data-driven engine for connecting underwriters, policyholders, and risk capital across the insurance value chain, but its latest filings suggest the engine is still in the garage while the mechanics argue over the colour of the paint. The company’s March 2026 10-Q shows $273.3m in revenues against a $1.37bn loss from the prior period, a mismatch so pronounced it makes the glossy product graphics feel like corporate theatre. The balance sheet, meanwhile, still carries $1.45bn in cash-enough to fund operations for a little while longer but not quite enough to justify the ‘reimagine insurance’ strapline emblazoned across the home page.

The platform’s core offering, the Accelerant Risk Exchange, is described on the product page as a tech-fuelled data-driven platform designed to ‘power connections across the specialty insurance value chain’, a sentence that reads like a buzzword bingo card won by a committee that forgot to read the instructions. The exchange’s promise to ‘ingest data from disparate data environments and pool it into a single, digestible dataset augmented with third-party data’ sounds impressive until you notice the company’s operating cash flow was a negative $21.4m for the quarter, a figure that suggests the vaunted data mojo hasn’t yet translated into the kind of cash-generative momentum that keeps finance chiefs awake at night. The company’s latest newsroom is a graveyard of press releases-‘Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call’, ‘Accelerant Announces First Quarter 2026 Results’-each one a polite reminder that the story is still being written in pencil rather than ink (source: Technology | Accelerant Risk Exchange, https://accelerant.ai/the-technology/; 10-Q, period ending 2026-03-31; Resources Archive | Accelerant Risk Exchange, https://accelerant.ai/resources/).

The company’s SEC filings read like a ledger of regulatory transparency: 144s, 4s, and 10-Qs tumble out of EDGAR in a steady rhythm, each one a digital breadcrumb trail leading back to a balance sheet that still can’t decide whether it’s a growth story or a turnaround. The latest 10-Q shows $273.3m in revenue against a $1.37bn loss from the prior year, a mismatch so stark it makes even the most forgiving analyst slow the read down. The company’s cash and cash equivalents stood at $1.45bn as of March 2026, a cushion that could fund operations for a little while longer but not indefinitely, especially given operating cash flow of negative $21.4m for the quarter. The filing also notes there were no reportable major customers accounting for 10% or more of revenue, which either proves impressive diversification or simply that the pipeline hasn’t scaled enough to matter-either way, it’s a fact that lands differently depending on who’s reading the tea leaves (source: ARX SEC EDGAR 10-Q, 2026-05-13, https://www.sec.gov/Archives/edgar/data/1997350/000199735026000011/arx-20260331.htm).

The company’s product positioning leans heavily on the idea of a ‘member-centric’ approach, promising underwriters ‘control over their destiny or growth potential’ in a market historically dominated by ‘incumbent players’-a framing that sounds like a rallying cry until you realise the company’s net income attributable to parent was a loss of $1.37bn for the prior period. The product images, meanwhile, feature cheerful graphics like ‘THE SECURITY MODUALS 20250224’, a typo that somehow feels more authentic than the marketing copy it accompanies, while the newsroom is a graveyard of quarterly announcements that read less like growth milestones and more like placeholder updates in a story still being written in pencil (source: Accelerant Launches the Accelerant Risk Exchange to Reimagine Insurance | Accelerant Risk Exchange, https://accelerant.ai/resources/accelerant-launches-the-accelerant-risk-exchange-to-reimagine-insurance/).

For all the talk of ‘reimagining insurance’, the evidence in EDGAR tells a different story. Revenues of $273.3m for the quarter ending March 2026 sit against a $1.37bn loss from the prior year, while operating cash flow of negative $21.4m suggests the platform’s data-driven engine is still burning through cash faster than it’s generating it. The company’s cash position of $1.45bn is a temporary cushion, not a structural moat, and the latest filings do not yet show a clear path to profitability. The absence of any single customer accounting for 10% or more of revenue may be diversification by design or simply a reflection of a pipeline that hasn’t yet scaled, but either way it’s a fact that doesn’t change the math on the income statement. The company’s product graphics, typographical errors included, and its newsroom of quarterly announcements, do not alter the balance sheet reality: the platform’s promise remains unproven in the numbers (source: ARX SEC EDGAR 10-Q, 2026-05-13, https://www.sec.gov/Archives/edgar/data/1997350/000199735026000011/arx-20260331.htm; Resources Archive | Accelerant Risk Exchange, https://accelerant.ai/resources/).

The company’s SEC filing index is a monument to transparency, with 144s, 4s, and 10-Qs tumbling out of EDGAR in a steady rhythm, each one a digital breadcrumb trail leading back to a balance sheet that still can’t decide whether it’s a growth story or a turnaround. The latest 10-Q shows $273.3m in revenue against a $1.37bn loss from the prior year, a mismatch so stark it makes even the most forgiving analyst slow the read down. The company’s cash and cash equivalents stood at $1.45bn as of March 2026, a cushion that could fund operations for a little while longer but not indefinitely, especially given operating cash flow of negative $21.4m for the quarter. The filing also notes there were no reportable major customers accounting for 10% or more of revenue, which either proves impressive diversification or simply that the pipeline hasn’t scaled enough to matter-either way, it’s a fact that lands differently depending on who’s reading the tea leaves (source: ARX SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=1997350).

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
ARX
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

ARX technical readout

Trend strength (ADX 14)
12.2
Average true range (ATR 14)
0.8697
ATR as % of price
5.91%
Volatility compression (ATR14/ATR50)
1.02x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

ARX evidence rails

Atlas uses the specific public rails available for ARX: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on ARX

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for ARX Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep ARX research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

ARX FAQ

What is Accelerant Holdings (ARX)?Accelerant Holdings (ARX) has a latest verified close of 12.29, up 0.24%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...

Accelerant Holdings (ARX) has a latest verified close of 12.29, up 0.24%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for ARX?Accelerant Holdings (ARX) has a latest verified close of 12.29, up 0.24%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...

Accelerant Holdings (ARX) has a latest verified close of 12.29, up 0.24%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ARX under USA Stocks for browsing.

How often is the ARX page updated?The ARX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The ARX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for ARX?The ARX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ARX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The ARX file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:ARX. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on ARX?Yes. The workstation can open ARX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open ARX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this ARX page investment advice?No. The ARX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The ARX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →